Navigation Links
Sysmex America Names National Sales Director
Date:10/8/2009

MUNDELEIN, Ill., Oct. 8 /PRNewswire/ -- Sysmex America, Inc. today announced that Tom Lindsay has been named as the company's National Director of Sales. Lindsay will be responsible for sales strategy development and implementation, customer loyalty initiatives and professional development and retention of the company's sales professionals.

"The heart of Tom's leadership at Sysmex America will focus on cross-functional collaboration that enables Sysmex to achieve its growth objectives. His strong leadership skills in strategic planning and organizational development and his financial acumen will serve us well as the company continues its pursuit as a world leader in diagnostics and information systems," said Robert Degnan, Vice President of Sales. Lindsay will report directly to the Vice President of Sales. The company's five regional sales directors and the non-acute segment director will report to Lindsay.

Prior to joining Sysmex America, Lindsay served in the IVD diagnostics market for more than twenty years and most recently, as a regional business manager for Roche Diagnostics Corporation. His tenure with Roche included key roles in sales, international collaboration projects, professional development, and merger integration. While with Roche Diagnostics Corporation, Lindsay was the recipient of many performance awards including the Principle Quest Award and the Hubert Rehkaemper Award. He was also a five-time recipient of the President's Award.

Lindsay received his bachelor's of science in biology with a minor in chemistry from St. Cloud University, Minnesota. He has professional training in the areas of executive and economic value selling and building competitive immunity, among others.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/usa.

SOURCE Sysmex America


'/>"/>
SOURCE Sysmex America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Clears Sysmex XE-2100D Hematology Analyzer for Blood Processing Center Quality Control Release Testing
2. Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society
3. Sysmex America Debuts High-end Sample Management System During AACC
4. Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems
5. Sysmex America Names Industry Veteran to Business Development Post
6. Sysmex America Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
7. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
8. BioReference Laboratories Partners With Sysmex America
9. Siemens and Sysmex Renew Global Agreement
10. Sysmex Corporation Announces Organizational Changes
11. Sysmex America Introduces On Demand Middleware Training Tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: